rs1555095933
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000260.4(MYO7A):c.4184dupA(p.Tyr1396ValfsTer8) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000260.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.4184dupA | p.Tyr1396ValfsTer8 | frameshift_variant | Exon 32 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.4184dupA | p.Tyr1396ValfsTer8 | frameshift_variant | Exon 32 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.4151dupA | p.Tyr1385ValfsTer8 | frameshift_variant | Exon 33 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.1727dupA | p.Tyr577ValfsTer8 | frameshift_variant | Exon 12 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.2024dupA | non_coding_transcript_exon_variant | Exon 15 of 32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Usher syndrome type 1 Pathogenic:2
The frameshift c.4184dup (p.Tyr1396ValfsTer8) variant) in the MYO7A gene has been reported to be associated with MYO7A related disorder (Wang, Rongrong et al.,2017). The variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. This variant causes a frameshift starting with codon Tyrosine 1396, changes this amino acid to Valine residue, and creates a premature Stop codon at position 8 of the new reading frame, denoted p.Tyr1396ValfsTer8. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. -
The variant is not observed in the gnomAD v2.1.1 dataset. Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with MYO7A related disorder (ClinVar ID: VCV000557498). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Usher syndrome Pathogenic:1
- -
not provided Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 557498). This sequence change creates a premature translational stop signal (p.Tyr1396Valfs*8) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 28281779). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at